Global Nattokinase Market Insights Forecasts to 2033

• The Global Nattokinase Market Size was Valued at USD 30.52 Million in 2023
• The Market Size is Growing at a CAGR of 3.01% from 2023 to 2033
• The Worldwide Nattokinase Market Size is Expected to Reach USD 41.06 Million by 2033
• North America is Expected to Grow the fastest during the forecast period.

The Nattokinase Market Size is Anticipated to Exceed USD 41.06 Million by 2033, Growing at a CAGR of 3.01% from 2023 to 2033.

Market Overview

Nattokinase is an enzyme derived from natto which is a fermented traditional soybean product and has been an essential component of Japanese cuisine for centuries. Bacillus subtilis bacteria make nattokinase (NK) when soybeans are fermented. Nattokinase is a strong protein that breaks up blood clots and is used to treat heart problems. Natto is made by soaking and cooking soybeans before mixing them with Bacillus subtilis and fermenting them for up to 24 hours at 40°C. The natto is then cooled and matured in the refrigerator for up to a week to allow for the development of stringiness. It comprises vitamins, amino acids, proteins, carbohydrates, lipids, minerals, and dietary fibers. Natto includes nattokinase, a polypeptide consisting of 275 amino acid residues with anticoagulant, fibrinolytic, blood pressure-lowering, and antioxidant properties. Natto is regarded as an acquired taste due to its intense aroma, flavor, and sticky, slimy texture. The growing tendency of health-conscious consumers and vegetarians towards plant-based protein sources is driving up the need for natto in the market. Customers are increasingly wary of synthetic compounds, which are driving the nattokinase market. They demand natural substitutes with beneficial health effects and no negative side effects. Nattokinase is a natural enzyme, which is why it is increasingly used in supplement manufacture. Another key element driving nattokinase market sales is the increased customer preference for supplements that enhance overall health and well-being.

Report Coverage

This research report categorizes the market for the nattokinase market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the nattokinase market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the nattokinase market.

Driving Factors

A major driver boosting the nattokinase market is the shift toward natural and functional supplements. The increasing prevalence of cardiovascular disorders such as hypertension, heart disease, stroke, high cholesterol, deep vein thrombosis (DVT), and chest pain (angina) is projected to drive the market. Furthermore, producers in the nattokinase market are constantly spending on R&D to innovate and introduce new products, which is another key driver of the nattokinase market.

Restraining Factors

One of the major restraining factors is nattokinase's "blood thinner" effect, as well as bleeding issues that warrant additional cautions and warnings. The enzyme is likely to lower blood pressure, which is concerning if it decreases drastically.

Market Segmentation

The nattokinase market share is classified into type and application.

• The 2,000 to 5,000 FU segment holds the highest market share through the forecast period.

Based on the type, the nattokinase market is categorized into 2,000 to 5,000 FU, 5,000 to 10,000 FU, 10,000 to 15,000 FU, and 15,000 to 20,000 FU. Among these, the 2,000 to 5,000 FU segment holds the highest market share through the forecast period. The significant proportion of this market segment in the global industry landscape can be attributed to the safe dosage of nattokinase, which is discovered to be between 100 and 200 mg per day. This is equivalent to 2,000 to 5,000 FU.

• The nutraceuticals segment dominated the market with the largest revenue share over the forecast period.

Based on the application, the nattokinase market is categorized into nutraceuticals, food additives, pharmaceuticals, and others. Among these, the nutraceuticals segment dominated the market with the largest revenue share over the forecast period. Customers are actively looking for natural and efficient supplements to maintain health for people who are conscious of well-being and health. Functional foods and dietary supplements are forms of nutraceuticals, which are regarded as secure and advantageous solutions. Because heart disease is so common, nutraceuticals with nattokinase are advertised as preventive measures for cardiovascular health, a major global concern.

Regional Segment Analysis of the Nattokinase Market 

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

Asia Pacific is anticipated to hold the largest share of the nattokinase market over the predicted timeframe.

Asia Pacific is projected to hold the largest share of the nattokinase market over the forecast period. Nattokinase has been utilized traditionally for generations in countries such as China and Japan. Nattokinase's strong market position in these places can be attributed in large part to its historical and cultural use and acceptability. The significance of cardiovascular health is also becoming more widely recognized in this region. Probiotics, vitamins, and minerals are just a few of the nutritional advantages of natto, a fermented soybean product. Demand for natural, nutrient-rich foods such as natto is predicted to grow in the region as consumers prioritize health and wellness in increasing quantities. Consumers are looking for simple yet wholesome food options as urban lifestyles get busier. This requirement is fulfilled by natto, which is a ready-to-eat, easy source of important nutrients and protein.

North America is expected to grow at the fastest CAGR growth in the nattokinase market during the forecast period. The market for nattokinase is growing as a result of consumers seeking increasingly more natural health supplements to enhance their general well-being. Heart disease is the primary cause of death in the area due to the high frequency of cardiovascular disorders. The introduction of nattokinase is being driven by the demand for efficient therapeutic and preventive options. According to the American Heart Association, in 2020, 928,741 fatalities in the US were attributable to cardiovascular disease (CVD), which continues to be the leading cause of death.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the nattokinase market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Japan Bio Science Laboratory Co., Ltd.
• Novonesis Group
• Creative Enzymes
• Weidan Biotechnology Co., Ltd.
• BIO-CAT
• Bioven Ingredients
• Eiffel Biotech
• Daiwa Pharmaceutical Co. Ltd.
• Contek Life Science Co., Ltd.
• Sungen Bioscience Co.,Ltd
• Vedan Biotechnology
• Toyo Hakko Co., Ltd.
• Belle Chemical
• Hexon Laboratories Private Limited
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In March 2023, To raise awareness of the benefits of natto, traditional Japanese cuisine that has improved the health of Japanese people for generations, the Japan Natto Cooperative Society Federation launched a new website titled "Natto Power Japanese Fermented Food Natto, the Key to Better Living ".

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the nattokinase market based on the below-mentioned segments: 

Global Nattokinase Market, By Type

• 2,000 to 5,000 FU
• 5,000 to 10,000 FU
• 10,000 to 15,000 FU
• 15,000 to 20,000 FU

Global Nattokinase Market, By Application

• Nutraceuticals
• Food Additives
• Pharmaceuticals
• Others

Global Nattokinase Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa